| P50 | author | Fawziah Marra | Q88203097 |
| P2093 | author name string | Mehdi Najafzadeh | |
| | Mei Chong | |
| P2860 | cites work | The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003 | Q21257242 |
| | The incidence of herpes zoster in a United States administrative database | Q24549730 |
| | Epidemiology of varicella zoster virus infection in Canada and the United Kingdom | Q24618133 |
| | THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS | Q24684507 |
| | Similar herpes zoster incidence across Europe: results from a systematic literature review | Q26824836 |
| | The incidence of herpes zoster | Q28109329 |
| | Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study | Q28111909 |
| | Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox | Q28111950 |
| | What does epidemiology tell us about risk factors for herpes zoster? | Q28111975 |
| | A Population-Based Study of the Incidence and Complication Rates of Herpes Zoster Before Zoster Vaccine Introduction | Q28112193 |
| | Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program | Q28248854 |
| | A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults | Q28254168 |
| | Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States | Q28300462 |
| | Systematic review of incidence and complications of herpes zoster: towards a global perspective. | Q33795551 |
| | Herpes zoster in Germany. A retrospective analyse of SHL data | Q33905625 |
| | Herpes zoster and postherpetic neuralgia surveillance using structured electronic data | Q34047979 |
| | Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study | Q34064838 |
| | Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination | Q34158156 |
| | Racial differences in the occurrence of herpes zoster | Q34319963 |
| | Clinical practice: Herpes zoster | Q34358014 |
| | Clinical practice. Herpes zoster | Q34768980 |
| | Varicella vaccination alters the chronological trends of herpes zoster and varicella | Q35035512 |
| | A systematic review and meta-analysis of risk factors for postherpetic neuralgia | Q36389515 |
| | Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases | Q36932760 |
| | Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia | Q37048037 |
| | Hospitalizations to treat herpes zoster in older adults: causes and validated rates | Q37235263 |
| | Increasing incidence of herpes zoster among Veterans | Q37697182 |
| | Examination of links between herpes zoster incidence and childhood varicella vaccination | Q38423324 |
| | Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance. | Q38591235 |
| | Characteristics of patients with herpes zoster on presentation to practitioners in France | Q38944095 |
| | Secular trends in the epidemiology of shingles in Alberta | Q40243482 |
| | Varicella | Q40278402 |
| | Postherpetic neuralgia--pathogenesis, treatment, and prevention | Q40990582 |
| | Incidence of herpes zoster and its complications in Germany, 2005-2009. | Q42186997 |
| | Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany | Q42281395 |
| | Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older. | Q43508371 |
| | Lymphocyte responses to varicella zoster virus in the elderly | Q43611827 |
| | Evidence of increasing frequency of herpes zoster management in Australian general practice since the introduction of a varicella vaccine | Q43637155 |
| | Gender difference in the incidence of shingles. | Q50739543 |
| | Shingles in Alberta: before and after publicly funded varicella vaccination. | Q51226815 |
| | Gender as an independent risk factor for herpes zoster: a population-based prospective study. | Q51816580 |
| | Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom | Q56768031 |
| | Population-based study of herpes zoster and its sequelae | Q72112939 |
| | Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database | Q78304911 |
| | Herpes zoster and exposure to the varicella zoster virus in an era of varicella vaccination | Q82520197 |
| | Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster | Q83117567 |
| | Epidemiology of herpes zoster and its relationship to varicella in Japan: A 10-year survey of 48,388 herpes zoster cases in Miyazaki prefecture | Q84782322 |
| | The incidence of varicella and herpes zoster in Taiwan during a period of increasing varicella vaccine coverage, 2000-2008 | Q84926686 |
| P433 | issue | 1 | |
| P921 | main subject | Canada | Q16 |
| | herpes zoster | Q182155 |
| P304 | page(s) | 589 | |
| P577 | publication date | 2016-10-20 | |
| P1433 | published in | BMC Infectious Diseases | Q15759919 |
| P1476 | title | Increasing incidence associated with herpes zoster infection in British Columbia, Canada | |
| P478 | volume | 16 | |